Global Blood Culture Test Market Overview:
The growing number of sepsis cases and high cost of treatment and rising geriatric population will boost global blood culture test market. Blood culture tests are done to identify the existence of microorganisms including bacteria or fungi in the blood. It is generally used to determine the occurrence of infection, identify the contributing agents and to guide the proper treatment necessary to a patient. Additionally, it is used to recognize a blood infection which if otherwise left unnoticed can lead to a serious and fatal condition called sepsis. Some of the key players profiled in the study are Becton, Dickinson and Company (United States), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (United States), Cepheid, Inc. (United States), Abbott Laboratories (United States), Nanosphere, Inc. (United States), Roche Diagnostics (Switzerland), Beckman Coulter (United States), Bruker Corporation (United States) and IRIDICA (United States). According to Market Analyst at AMA, the Global Blood Culture Test market may see a growth rate of 9.1%
On the basis of geography, the market of Blood Culture Test has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Technology , the sub-segment i.e. Culture-based Technology will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technique, the sub-segment i.e. Conventional will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals Laboratories will boost the Blood Culture Test market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- High Occurrence of Bloodstream Infections
- High Prevalence of Infectious Diseases
- Growing Number of Regulatory Approvals & New Product Launches
- High Adoption due to Rising Demand for Rapid Diagnostic Techniques
- Rising Concern about the High Cost of Automated Instruments
- Dearth of Skilled Laboratory Technicians
- Identification of Antibiotic-Resistant Microorganisms
- Huge Opportunity in Emerging Economies
- Survival of Players Offering Conventional Blood Culture Products
- Intense Competition among the Players
On 8th April 2019, BD (Becton, Dickinson and Company), a leading global medical technology company has announced global availability of BD BACTEC™; platelet quality control media, which allows microbiology laboratories, blood banks and transfusion services to identify contaminated platelet units.
The global blood culture tests market is highly competitive due to the presence of key market players. To surge the adoption of automated blood culture tests, many key players are establishing or strengthening their research associations to improve safe and efficient products. Additionally, new market players have to develop efficient as well as cost-effective blood culture tests to compete against existing and upcoming market entrants and rise the approval of their products.
Target Audience:Molecular Diagnostic Companies, Manufacturers of Clinical Microbiology Instruments and Consumables, Venture Capitalists, Research and Consulting Firms, Clinical Diagnostic Laboratories, Government Bodies, Government and Private Research Center and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Blood Culture Test market on the basis of product [Consumables [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessories], Instruments [Bacterial Infections, Fungal Infections, Mycobacterial Infections, Laboratory Equipment, Automated Blood Culture Systems] and Software & Services [Bacterial Infections, Fungal Infections, Mycobacterial Infections]] , application [Bacterial Infections, Fungal Infections and Mycobacterial Infections], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Blood Culture Test market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Blood Culture Test industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are T2 Biosystems (United States), Danaher Corporation (United States) and Luminex Corporation (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Blood Culture Test market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.